These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7755342)

  • 1. [Endocrine involvement in immunotherapy].
    Tartour E; Schlumberger M; Dorval T; Baudin E; Fridman WH
    Ann Endocrinol (Paris); 1995; 56(2):143-8. PubMed ID: 7755342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.
    Reid I; Sharpe I; McDevitt J; Maxwell W; Emmons R; Tanner WA; Monson JR
    Br J Cancer; 1991 Nov; 64(5):915-8. PubMed ID: 1931616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
    Pichert G; Jost LM; Zöbeli L; Odermatt B; Pedia G; Stahel RA
    Br J Cancer; 1990 Jul; 62(1):100-4. PubMed ID: 2390468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of autoimmune hypothyroidism induced by lymphokine-activated killer (LAK) cell therapy: in vitro inhibition of human thyroid function by interleukin-2 in the presence of autologous intrathyroidal lymphocytes.
    Sato K; Yamazaki K; Shizume K; Yamakawa Y; Satoh T; Demura H; Kanaji Y; Obara T; Fujimoto Y; Aiba M
    Thyroid; 1993; 3(3):179-88. PubMed ID: 8257856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?].
    Schuppert F; Müller-Kunert E; Stöcker W; Bokemeyer C; Schmoll HJ; von zur Mühlen A; Rambusch EG
    Med Klin (Munich); 1996 Feb; 91(2):59-65. PubMed ID: 8850099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease.
    Schuppert F; Rambusch E; Kirchner H; Atzpodien J; Kohn LD; von zur Mühlen A
    Thyroid; 1997 Dec; 7(6):837-42. PubMed ID: 9459625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level.
    Chikkala NF; Lewis I; Ulchaker J; Stanley J; Tubbs R; Finke JH
    Cancer Res; 1990 Feb; 50(4):1176-82. PubMed ID: 2297766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma.
    Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A
    J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid functions in patients treated with interleukin-2 and lymphokine-activated killer cells.
    Kung AW; Lai CL; Wong KL; Tam CF
    Q J Med; 1992 Jan; 82(297):33-42. PubMed ID: 1332102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
    Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of corticosteroid on lymphokine-activated killer (LAK) activity and the change of membrane antigen phenotype on PBMC after IL2 incubation with reference to the evaluation in vitro].
    Yoshimura A
    Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):211-21. PubMed ID: 2376610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
    Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
    Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro.
    Higuchi CM; Thompson JA; Lindgren CG; Gillis S; Widmer MB; Kern DE; Fefer A
    Cancer Res; 1989 Dec; 49(23):6487-92. PubMed ID: 2479463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response.
    Kruit WH; Bolhuis RL; Goey SH; Jansen RL; Eggermont AM; Batchelor D; Schmitz PI; Stoter G
    J Clin Oncol; 1993 May; 11(5):921-4. PubMed ID: 8487055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha.
    Jacobs EL; Clare-Salzler MJ; Chopra IJ; Figlin RA
    J Immunother (1991); 1991 Dec; 10(6):448-55. PubMed ID: 1768679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
    Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
    J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
    Balázs C
    Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
    Koh LK; Greenspan FS; Yeo PP
    Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.